HomeCompareMRCHF vs CHD

MRCHF vs CHD: Dividend Comparison 2026

MRCHF yields 3.32% · CHD yields 1.27%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 CHD wins by $2.4K in total portfolio value· pulled ahead in Year 7
10 years
MRCHF
MRCHF
● Live price
3.32%
Share price
$22.00
Annual div
$0.73
5Y div CAGR
-3.4%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$23.9K
Annual income
$282.66
Full MRCHF calculator →
CHD
CHD
● Live price
1.27%
Share price
$93.91
Annual div
$1.19
5Y div CAGR
23.1%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$26.4K
Annual income
$1,292.51
Full CHD calculator →

Portfolio growth — MRCHF vs CHD

📍 CHD pulled ahead of the other in Year 7

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodMRCHFCHD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, MRCHF + CHD cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
MRCHF pays
CHD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

MRCHF
Annual income on $10K today (after 15% tax)
$282.57/yr
After 10yr DRIP, annual income (after tax)
$240.26/yr
CHD
Annual income on $10K today (after 15% tax)
$107.94/yr
After 10yr DRIP, annual income (after tax)
$1,098.63/yr
At 15% tax rate, CHD beats the other by $858.37/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of MRCHF + CHD for your $10,000?

MRCHF: 50%CHD: 50%
100% CHD50/50100% MRCHF
Portfolio after 10yr
$25.1K
Annual income
$787.58/yr
Blended yield
3.13%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on CHD right now

MRCHF
No analyst data
Altman Z
2.6
Piotroski
7/9
CHD
Analyst Ratings
18
Buy
15
Hold
1
Sell
Consensus: Buy
Price Target
$98.40
+4.8% upside vs current
Range: $82.00 — $110.00
Altman Z
4.9
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

MRCHF buys
0
CHD buys
0
No recent congressional trades found for MRCHF or CHD in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricMRCHFCHD
Forward yield3.32%1.27%
Annual dividend / share$0.73$1.19
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR-3.4%23.1%
Portfolio after 10y$23.9K$26.4K
Annual income after 10y$282.66$1,292.51
Total dividends collected$3.1K$5.5K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples

Year-by-year: MRCHF vs CHD ($10,000, DRIP)

YearMRCHF PortfolioMRCHF Income/yrCHD PortfolioCHD Income/yrGap
1$11,021$321.13$10,856$156.32+$165.00MRCHF
2$12,112$319.52$11,811$195.24+$301.00MRCHF
3$13,277$317.02$12,883$244.38+$394.00MRCHF
4$14,520$313.73$14,091$306.64+$429.00MRCHF
5$15,846$309.76$15,463$385.88+$383.00MRCHF
6$17,261$305.19$17,033$487.17+$228.00MRCHF
7← crossover$18,769$300.12$18,843$617.36$74.00CHD
8$20,378$294.63$20,947$785.72$569.00CHD
9$22,093$288.79$23,419$1,004.91$1.3KCHD
10$23,922$282.66$26,350$1,292.51$2.4KCHD

MRCHF vs CHD: Complete Analysis 2026

MRCHFStock

H.U. Group Holdings, Inc., through its subsidiaries, provides laboratory testing products and services in Japan. The company offers lab testing and its related services to medical institutions; self-medication services; food, environment, and cosmetic testing services; and testing services through corporate health insurance associations. It also researches, develops, manufactures, and sells in vitro diagnostic devices, which includes the LUMIPULSE, an automatic chemiluminescent enzyme immunoassay system that offers reagents for infectious disease, cancer, and lifestyle disease to medical institutions and testing centers; and ESPRINE, a rapid diagnostics kit series for influenza, hepatitis B, and the novel coronavirus, as well as supplies ingredients for test drugs. In addition, the company provides support services related to hospital administration work, including aid for surgical procedures and endoscope room work, inspection and maintenance services for medical equipment, and in-hospital logistics management and transportation services; and rents and sells nursing-care equipment and supplies. Further, it offers home-visit nursing care services. The company was formerly known as Miraca Holdings Inc. and changed its name to H.U. Group Holdings, Inc. in July 2020. H.U. Group Holdings, Inc. was incorporated in 1950 and is headquartered in Tokyo, Japan.

Full MRCHF Calculator →

CHDConsumer Staples

Church & Dwight Co., Inc. develops, manufactures, and markets household, personal care, and specialty products. It operates through three segments: Consumer Domestic, Consumer International, and Specialty Products Division. The company offers cat litters, carpet deodorizers, laundry detergents, and baking soda, as well as other baking soda based products under the ARM & HAMMER brand; condoms, lubricants, and vibrators under the TROJAN brand; stain removers, cleaning solutions, laundry detergents, and bleach alternatives under the OXICLEAN brand; battery-operated and manual toothbrushes under the SPINBRUSH brand; home pregnancy and ovulation test kits under the FIRST RESPONSE brand; depilatories under the NAIR brand; oral analgesics under the ORAJEL brand; laundry detergents under the XTRA brand; gummy dietary supplements under the L'IL CRITTERS and VITAFUSION brands; dry shampoos under the BATISTE brand; water flossers and replacement showerheads under the WATERPIK brand; FLAWLESS products; cold shortening and relief products under the ZICAM brand; and oral care products under the THERABREATH brand. Its specialty products include animal productivity products, such as MEGALAC rumen bypass fat, a supplement that enables cows to maintain energy levels during the period of high milk production; BIO-CHLOR and FERMENTEN, which are used to reduce health issues associated with calving, as well as provides needed protein; and CELMANAX refined functional carbohydrate, a yeast-based prebiotic. The company offers sodium bicarbonate; and cleaning and deodorizing products. It sells its consumer products through supermarkets, mass merchandisers, wholesale clubs, drugstores, convenience stores, home stores, dollar and other discount stores, pet and other specialty stores, and websites and other e-commerce channels; and specialty products to industrial customers and livestock producers through distributors. The company was founded in 1846 and is headquartered in Ewing, New Jersey.

Full CHD Calculator →
📬

Get this MRCHF vs CHD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

MRCHF vs SCHDMRCHF vs JEPIMRCHF vs OMRCHF vs KOMRCHF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.